2007
DOI: 10.1111/j.1399-6576.2007.01352.x
|View full text |Cite
|
Sign up to set email alerts
|

Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision

Abstract: The set of guidelines for good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents, which was developed following an international consensus conference in Copenhagen, has been revised and updated following the second consensus conference in Stockholm in 2005. It is hoped that these guidelines will continue to help researchers in the field and assist the pharmaceutical industry and equipment manufacturers in enhancing the standards of the studies they sponsor.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
611
0
20

Year Published

2009
2009
2018
2018

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 582 publications
(636 citation statements)
references
References 59 publications
5
611
0
20
Order By: Relevance
“…Heart rate was also similar at baseline (85 [18] and 80 [15] beats Á min -1 , respectively). However, the lowest HR value recorded was less in the succinylcholine group compared with the rocuronium group (67 [12] vs. 74 [13] beats min -1 , respectively; P \ 0.001). In the succinylcholine group, 12 patients developed a decrease of MAP by more than 25% from baseline value for 60 s, necessitating the use of ephedrine, whereas in the rocuronium group, four patients required ephedrine (P = 0.067).…”
Section: Resultsmentioning
confidence: 85%
See 1 more Smart Citation
“…Heart rate was also similar at baseline (85 [18] and 80 [15] beats Á min -1 , respectively). However, the lowest HR value recorded was less in the succinylcholine group compared with the rocuronium group (67 [12] vs. 74 [13] beats min -1 , respectively; P \ 0.001). In the succinylcholine group, 12 patients developed a decrease of MAP by more than 25% from baseline value for 60 s, necessitating the use of ephedrine, whereas in the rocuronium group, four patients required ephedrine (P = 0.067).…”
Section: Resultsmentioning
confidence: 85%
“…A 7.0-or 8.0-mm tracheal tube was used for females and males, respectively. Intubating conditions, based on a scoring system proposed for good clinical research practice, were evaluated using the following variables 12 : ease of laryngoscopy, vocal cord position, and reaction to insertion of the tracheal tube and cuff inflation (diaphragmatic movement-coughing). Each of these variables was rated as excellent, good, or poor.…”
Section: Methodsmentioning
confidence: 99%
“…Exclusion criteria were: neuromuscular disease (muscular dystrophy, myasthenia gravis, myotonias or upper motor neurone lesions); renal or hepatic failure; a history of or predictors of difficult airway; hypermagnesaemia (> 1.02 mmol.l À1 ) or hypomagnesaemia (< 0.7 mmol.l À1 ); pregnancy or potential pregnancy; the use of drugs known to affect neuromuscular blockade; and allergy to drugs used in the study. The study followed the recommendations of Good Clinical Research Practice in Pharmacodynamic Studies of Neuromuscular Blocking Agents II: the Stockholm revision [13].…”
Section: Methodsmentioning
confidence: 99%
“…The transducer position was secured using a hand adapter (Hand Adapter â ; Organon Ltd), keeping the arm in the same position throughout the entire procedure. A temperature sensor was placed on the hypothenar region of the monitored hand [8,11,13].…”
Section: Methodsmentioning
confidence: 99%
“…Todos los métodos de medición cuantitativa del BNM han requerido de su validación comparándolo con la MMG. La AMG y la EMG están disponibles y son mucho más fáciles de usar en quirófano 37 . Debido a la potencial morbilidad asociada con bloqueos neuromusculares residuales, la monitorización perioperatoria (cualquiera que sea el método empleado) de la función neuromuscular es esencial.…”
Section: Monitorización Neuromuscularunclassified